Year: 2020
Type: article
Abstract: BACKGROUND: Immunogenic cell death (ICD) is a peculiar modality of cellular demise that elicits adaptive immune responses and triggers T cell-dependent immunity. METHODS: Fluorescent biosensors were employed for an unbiased drug screen approach aiming at the identification of ICD enhancers. RESULTS: Here, we discovered thiostrepton as an enhancer of ICD able to boost chemotherapy-induced ATP release, calreticulin exposure and high-mobility group box 1 exodus. Moreover, thiostrepton enhanced anticancer immune responses of oxaliplatin (OXA) in vivo in immunocompetent mice, yet failed to do so in immunodeficient animals. Consistently, thiostrepton combined with OXA altered the ratio of cytotoxic T lymphocytes to regulatory T cells, thus overcoming immunosuppression and reinstating anticancer immunosurveillance. CONCLUSION: Altogether, these results indicate that thiostrepton can be advantageously combined with chemotherapy to enhance anticancer immunogenicity.
Authors: Yan Wang, Wei Xie, Juliette Humeau, Guo Chen, Peng Liu, Jonathan Pol, Zhen Zhang, Oliver Kepp, Guido Kroemer
Institutions: Inserm, Université Paris Cité, Fudan University, Institut Gustave Roussy, Centre de Recherche des Cordeliers, La Ligue Contre le Cancer, Université Paris-Saclay, Sorbonne Université, Nankai University, Shanghai Medical College of Fudan University, Fudan University Shanghai Cancer Center, Karolinska University Hospital, Karolinska Institutet, Hôpital Européen Georges-Pompidou
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $2,804
Funders: Association pour la Recherche sur le Cancer, Seerave Foundation, E-Rare, European Commission, Agence Nationale de la Recherche, Fondation Leducq, Institut National de la Santé et de la Recherche Médicale, National Natural Science Foundation of China, Fondation pour la Recherche Médicale, Ligue Contre le Cancer, China Scholarship Council, Centre National de la Recherche Scientifique, Institut Universitaire de France, Institut National Du Cancer, Institut Gustave-Roussy, European Research Area Network on Cardiovascular Diseases, High-end Foreign Experts Recruitment Plan of China, Labex Immuno-Oncology
OpenAlex ID: W3013209147
